New figures show the number of babies admitted to hospital with respiratory viruses has trebled in just a year, according to Manx Care.

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...